News and Press Releases

Spur provides update on FLT201 and planned phase III clinical trial

8 July 2024 -- London, UK -- Syncona Ltd, a leading life science investor focused on creating, building and scaling global leaders in life science, notes that its portfolio company...

Category: Clinical Trials, Other, Pharmaceutical
Posted: July 8, 2024

2nd Floor, 8 Bloomsbury Street, London, WC1B 3SR

Phase 2b Influenza Field Study Contract

hVIVO to enrol up to 1,000 healthy volunteers as part of a multicentre field study testing an influenza drug candidate, with hVIVO selected as the sole UK clinical site Largest...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024

40 Bank Street, Floor 24, London, E14 5NR

1nhaler hires pharma industry leaders for key roles ahead of clinical trials

Edinburgh-based 1nhaler has appointed two experts in inhalation and respiratory medicines to the board as it looks to accelerate the development and market-readiness of its novel single use inhaler device....

Category: Clinical Trials, Other
Posted: July 1, 2024

1 (2F3) Jessfield Terrace, Edinburgh, Scotland, EH6 4JR

New study investigates link between toxic element exposure and Alzheimer’s disease risk

25 June 2024 -- Malvern, UK -- A comprehensive study is currently underway to clarify the relationship between Alzheimer's disease and related dementias (AD/ADRD) and four toxic elements: lead, mercury, arsenic...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 27, 2024

Enigma Business Park Grovewood Road Malvern WR14 1XZ United Kingdom

Elemental Machines Expands European Presence and Enhances AI-Predicted Health Score

27 June 2024 -- Florence, Italy -- Elemental Machines, a leader in smart lab and manufacturing connectivity solutions, is pleased to announce they are consolidating their position in the EU...

Category: BioManufacturing, Pharmaceutical
Posted: June 27, 2024

Viale Giacomo Matteotti, 15 50121 Firenze FI, Italy

WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research

26 June 2024 -- New Jersey, US -- WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, and the Multi-Regional Clinical Trials Center of Brigham...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 26, 2024

212 Carnegie Center, Suite 301, Princeton, NJ 08540, USA

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024

Greenville, South Carolina, 29609

Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials June 24 2024, California, US, -Bio-Rad Laboratories, Inc. (NYSE: BIO...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: June 24, 2024

Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Patients Most In Need Face Obstacles to Participating in Life-Saving Clinical Trials According to a New Milken Institute Report

24 June 2024 -- Washington, DC -- Clinical trials can provide the possibility to obtain novel treatments for conditions and diseases that are not yet commercially available. Yet, these lifesaving...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 24, 2024

730 15th Street NW Washington, DC 20005

New Phesi proof of concept demonstrates potential of AI-powered digital twins to replace external control arms in clinical trials

Study published in Bone Marrow Transplantation uses real-world clinical data to create virtual digital twin cohorts instead of placebo and standard-of-care comparator arms 20 June 2024 -- Massachusetts, US --...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: June 20, 2024

East Lyme, Connecticut, US

Basecamp Research launches ZymCTRL a world-first, open source, generative AI tool that designs enzymes for more sustainable industrial processes. ZymCTRL is the world’s first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives.

AI model able to produce sequences that produced functional enzymes with desirable characteristicsfor industrial applications. Basecamp Research field scientists collect samples during an expedition to Costa Rica on July 29,...

Category: BioManufacturing, Drug Delivery, Drug Discovery, Other
Posted: June 18, 2024

Unit 315, Clerkenwell Workshops 27 Clerkenwell Close London, EC1R 0AT

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024 17 June 2024 -- Pennsylvania, US -- CluePoints, provider...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 17, 2024

1000 Continental Drive, Suite 240, King of Prussia, PA 19406

China’s Innovent holds potential to change pancreatic cancer treatment landscape with bispecific antibody IBI389, says GlobalData

14 June 2024 - China-based Innovent Biologics recently presented phase 1 study results of its first-in-class anti-CLDN18.2/CD3 bispecific antibody (IBI389) for the treatment of advanced pancreatic cancer at the 2024...

Category: Biotechnology, Pharmaceutical
Posted: June 14, 2024

GlobalData, John Carpenter House, 7 Carmelite Street, London, EC4Y 0BS, United Kingdom

Tapinarof may mark Dermavant’s first atopic dermatitis approval, says GlobalData

Dermavant's VTAMA (tapinarof), a nonsteroidal, topical AhR-modulating agent, achieved positive phase 3 trial results in atopic dermatitis patients aged two and above, leading to Food and Drug Administration (FDA) acceptance...

Category: Drug Discovery, Pharmaceutical
Posted: June 13, 2024

GlobalData, John Carpenter House, 7 Carmelite Street, London, EC4Y 0BS, United Kingdom

Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative  

Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion   13 June 2024 -- Massachusetts, US -- Deep Genomics, the...

Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024

480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2